Anne-Margaux Mascarel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Anne-Margaux Mascarel has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ava Avalos
Careena Center for Health, Gaborone, Botswana
1 shared publication B. Chaulin
Department of Radiology, Hôpital Haut Lévêque, CHU de Bordeaux, Pessac, France
1 shared publicationC. Pontais
Hôpital Haut Lévêque, CHU de Bordeaux
1 shared publication- Clas Une
Instituto de Investigaciones en Salud, Universidad de Costa Rica, Costa Rica
1 shared publication Delphine Geffroy
1 shared publication- Francis Mégraud
INSERM U1312 Bric, Université de Bordeaux, Bordeaux, France
1 shared publication
Latest Publications
- 22 April 2024
- Published by Elsevier in Imagerie de la Femme
- Vol. 34 (2) , 89-92
Spécificités de la prise en charge diagnostique du cancer du sein chez la femme jeune
- 22 April 2024
- Published by Elsevier in Imagerie de la Femme
- Vol. 34 (2) , 89-92
Spécificités de la prise en charge diagnostique du cancer du sein chez la femme jeune
- 1 June 2006
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 6 (2) , 72-78
Association of serum pepsinogen with atrophic body gastritis in Costa Rica
Individuals with atrophic gastritis (AG), especially atrophic body gastritis (ABG), are at increased risk of developing gastric cancer. Serum concentrations of pepsinogens (PG) have been proposed as markers for ABG. The aim of this study was to determine the risk factors for AG and ABG and the potential of using serum PG concentrations to detect ABG in a dyspeptic population in Costa Rica, which is one of the countries with the highest incidence and mortality rates of gastric cancer in the world. Seven biopsy specimens, a fasting blood sample and a questionnaire concerning sociodemographic factors were obtained from 501 consecutive dyspeptic patients. The serum PGI level and the PGI/PGII ratios were significantly lower in patients with ABG than in other groups (PHelicobacter pylori were present in 93% of the patients and all those with peptic ulcers were positive. AG was associated with increased age, lower body mass index, high alcohol intake and low fruit consumption. ABG was associated with age, alcohol consumption and PGI/PGIIH. pylori infection, serum PG levels provide an assessment of ABG but it is necessary to introduce other serological and genetic markers in order to achieve a better specificity. Those markers could be serum antibodies to H. pylori-CagA, cytokine gene polymorphisms or others.
- 1 June 2006
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 6 (2) , 72-78
Association of serum pepsinogen with atrophic body gastritis in Costa Rica
Individuals with atrophic gastritis (AG), especially atrophic body gastritis (ABG), are at increased risk of developing gastric cancer. Serum concentrations of pepsinogens (PG) have been proposed as markers for ABG. The aim of this study was to determine the risk factors for AG and ABG and the potential of using serum PG concentrations to detect ABG in a dyspeptic population in Costa Rica, which is one of the countries with the highest incidence and mortality rates of gastric cancer in the world. Seven biopsy specimens, a fasting blood sample and a questionnaire concerning sociodemographic factors were obtained from 501 consecutive dyspeptic patients. The serum PGI level and the PGI/PGII ratios were significantly lower in patients with ABG than in other groups (PHelicobacter pylori were present in 93% of the patients and all those with peptic ulcers were positive. AG was associated with increased age, lower body mass index, high alcohol intake and low fruit consumption. ABG was associated with age, alcohol consumption and PGI/PGIIH. pylori infection, serum PG levels provide an assessment of ABG but it is necessary to introduce other serological and genetic markers in order to achieve a better specificity. Those markers could be serum antibodies to H. pylori-CagA, cytokine gene polymorphisms or others.
- 1 March 1994
- Published by Springer Nature in Abdominal Radiology
- Vol. 19 (2) , 160-161
Pancreatic castleman disease: CT findings
Computed tomography findings in a case of pancreatic localization of Castleman disease are presented correlated with histological findings. This is the second observation in the literature of pancreatic involvement with an unusual histological form.
- 1 March 1994
- Published by Springer Nature in Abdominal Radiology
- Vol. 19 (2) , 160-161
Pancreatic castleman disease: CT findings
Computed tomography findings in a case of pancreatic localization of Castleman disease are presented correlated with histological findings. This is the second observation in the literature of pancreatic involvement with an unusual histological form.